NexgenRx (TSE:NXG) has released an update.
NexgenRx, a Canadian Third-Party Administrator and Technology Solutions Provider, has reported a substantial 19% revenue increase and a positive EBITDA in its second quarter of 2024. The growth is attributed to the successful introduction of SaaS solutions and a strong sales pipeline. The company remains in a strong cash position, even after paying out dividends to shareholders.
For further insights into TSE:NXG stock, check out TipRanks’ Stock Analysis page.
